TransMedics officer granted RSUs and stock options

TransMedics Group, Inc. reported that company officer Matthew S. Forsyth received equity compensation on May 19, 2026.

Rhea-AI Filing Summary

TransMedics Group, Inc. reported that company officer Matthew S. Forsyth received equity compensation on May 19, 2026. He was granted 15,409 restricted stock units, each representing one share of common stock, and a stock option for 23,171 shares of common stock at an exercise price of $66.13 per share. The option expires on March 9, 2036 and vests 25% on March 9, 2027, with the remainder vesting in equal monthly installments over the following three years, subject to continued service. These awards increase his direct equity stake and align his compensation with the company’s share performance.

Insider Trade Summary

Grant/Award: 38,580 shares

Grant/Award 2 txns

Insider Forsyth Matthew S.

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	23,171	$0.00	$0.00
Grant/Award	Common Stock	15,409	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 23,171 contracts (Direct); Common Stock — 15,409 shares (Direct)

Footnotes (2)

1. F1. Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2. F2. The option vests as to 25% of the shares underlying the option on March 9, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Key Figures

RSU grant: 15,409 RSUs Option grant size: 23,171 shares Option exercise price: $66.13 per share +2 more

5 metrics

RSU grant 15,409 RSUs Each RSU equals one share of common stock

Option grant size 23,171 shares Stock option covering common stock

Option exercise price $66.13 per share Exercise price for 23,171-share stock option

Option expiration March 9, 2036 Expiration date of stock option grant

Initial option vesting 25% on March 9, 2027 First vesting tranche of stock option

Key Terms

restricted stock units, RSUs, Stock Option (Right to Buy), exercise price, +1 more

5 terms

restricted stock units financial

"Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Stock Option (Right to Buy) financial

"security_title": "Stock Option (Right to Buy)""

exercise price financial

"conversion_or_exercise_price": "66.1300""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests financial

"The option vests as to 25% of the shares underlying the option"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did TransMedics (TMDX) officer Matthew S. Forsyth receive?

Matthew S. Forsyth received 15,409 restricted stock units and a stock option for 23,171 shares. Each RSU represents one common share, and the option allows future purchases at a fixed $66.13 exercise price, subject to vesting conditions and continued service.

How do the new RSUs for TransMedics (TMDX) officer Matthew S. Forsyth work?

Forsyth was granted 15,409 restricted stock units, each equal to one TransMedics common share. These RSUs typically convert into shares over time as vesting conditions are met, directly linking a portion of his compensation to the company’s stock performance and long-term results.

What are the key terms of Matthew S. Forsyth’s new TransMedics (TMDX) stock option?

Forsyth received a stock option covering 23,171 TransMedics common shares at a $66.13 exercise price. The option expires March 9, 2036, vests 25% on March 9, 2027, and the rest vests in equal monthly installments over three additional years, contingent on continued service.

When do Matthew S. Forsyth’s TransMedics (TMDX) stock options and RSUs vest?

For the option, 25% of the 23,171 underlying shares vest on March 9, 2027, with the remaining shares vesting in equal monthly installments over the following three years. The RSUs follow their own vesting schedule tied to continued service, ultimately delivering common shares upon vesting.

Does the Form 4 show Matthew S. Forsyth buying or selling TransMedics (TMDX) stock on the market?

The Form 4 shows equity awards granted as compensation, not market trades. It reports an acquisition of RSUs and stock options at no cost, with a fixed $66.13 exercise price for the options, rather than open-market purchases or sales of existing TransMedics shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 06:47 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forsyth Matthew S.

(Last) (First) (Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER MASSACHUSETTS 01810

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		15,409(1)	A	$0	15,409	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$66.13	05/19/2026		A		23,171		(2)	03/09/2036	Common Stock	23,171	$0	23,171	D

Explanation of Responses:

1. Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

2. The option vests as to 25% of the shares underlying the option on March 9, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Remarks:

Senior Vice President, General Counsel and Secretary

	By: /s/ Gerardo Hernandez, Attorney-in-Fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)